Goldman Sachs analyst issues SELL recommendation for UPST on February 14, 2024 04:00PM ET. The previous analyst recommendation was Sell.UPST was trading at $26.46 at issue of the analyst recommendation.The...
Wedbush analyst issues UNDERPERFORM recommendation for UPST on February 14, 2024 04:00PM ET. The previous analyst recommendation was Underperform.UPST was trading at $26.46 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues SELL recommendation for UPST on February 14, 2024 04:00PM ET. The previous analyst recommendation was Sell.UPST was trading at $26.46 at issue of the analyst recommendation.The...
Wedbush analyst issues UNDERPERFORM recommendation for UPST on February 14, 2024 04:00PM ET. The previous analyst recommendation was Underperform.UPST was trading at $26.46 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues POSITIVE recommendation for NVDA on February 14, 2024 03:16PM ET. The previous analyst recommendation was Positive.NVDA was trading at $735.01 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for QCOM on February 13, 2024 03:57PM ET. The previous analyst recommendation was Overweight.QCOM was trading at $150.04 at issue of the analyst recommendation.The...
Wells Fargo analyst issues MARKET OUTPERFORM recommendation for PANW on February 12, 2024 03:01PM ET. The previous analyst recommendation was Market Outperform.PANW was trading at $371.095 at issue of the...
Wedbush analyst issues UNDERPERFORM recommendation for PANW on February 12, 2024 03:01PM ET. The previous analyst recommendation was Underperform.PANW was trading at $371.095 at issue of the analyst recommendation.The overall...
Rosenblatt Securities analyst issues BUY recommendation for QCOM on February 12, 2024 01:01PM ET. The previous analyst recommendation was Buy.QCOM was trading at $154.25 at issue of the analyst recommendation.The...
Wolfe Research analyst issues BUY recommendation for CRM on February 12, 2024 09:00AM ET. The previous analyst recommendation was Buy.CRM was trading at $290.8075 at issue of the analyst recommendation.The...
